Taiwan Universe BioMedicine Inc.
Selected as a startup company by FINDIT Matchmaking in the past two years
Update：2026/08/06
Industries
Main Industry
Biotechnology
Main Product/Service
Main Product
Innovative platform of enterovirus and influenza VLP vaccines
Promising option to combat viruses mutation
Provide a broad-spectrum prevention with better immunogenicity
Enable faster scaling-up
Innovative platform of enterovirus and influenza VLP vaccines
Promising option to combat viruses mutation
Provide a broad-spectrum prevention with better immunogenicity
Enable faster scaling-up
Founded Year
2023
Unified Business No.
94247033
Status
Active
Number of Employees
0
Total Paid-in
Capital
75,000,000 (NT$)
Location of Company
Taiwan
, Taipei City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Dr. Min-Shi Lee has more than 30 years experiences in vaccine research and development including 6 years R&D in USA vaccine company, and several national vaccine development projects of enterovirus, influenza H5N1, H7N9 and seasonal influenza. To strengthen and grow Taiwan’s vaccine business, Dr. Min-Shi Lee’s group has established a start-up company for developing bivalent enterovirus vaccines and seasonal influenza virus-like particle (VLP) vaccines and also expend to more diseases area through this innovative technology platforms.
PhD, Oxford University, UK
MPH, National Taiwan University
Investigator, NHRI, Taiwan (2005~)
Scientist, Aviron/Medimmune (1999~2005)
NIPM (former CDC), Taiwan (1993~1998)
>30 years for vaccine research including measles, JEV, influenza (FluMist licensed in USA) , PIV3, and EV71 (licensed in Taiwan)
Built Asia-Pacific Network for Enterovirus Surveillance (APNES)
PhD, Oxford University, UK
MPH, National Taiwan University
Investigator, NHRI, Taiwan (2005~)
Scientist, Aviron/Medimmune (1999~2005)
NIPM (former CDC), Taiwan (1993~1998)
>30 years for vaccine research including measles, JEV, influenza (FluMist licensed in USA) , PIV3, and EV71 (licensed in Taiwan)
Built Asia-Pacific Network for Enterovirus Surveillance (APNES)
